/
2012 HIV/AIDS surveillance in Europe 2012 HIV/AIDS surveillance in Europe

2012 HIV/AIDS surveillance in Europe - PowerPoint Presentation

aaron
aaron . @aaron
Follow
379 views
Uploaded On 2018-03-11

2012 HIV/AIDS surveillance in Europe - PPT Presentation

European Centre for Disease Prevention and Control Stockholm WHO Regional Office for Europe Copenhagen European Union and European Economic Area EUEEA 1 HIV infections diagnosed 2012 ID: 647044

2012 hiv aids europe hiv 2012 europe aids surveillance ecdc eea reported source infections men cases diagnoses diagnosed transmission

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "2012 HIV/AIDS surveillance in Europe" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

2012

HIV/AIDS surveillance in Europe

European Centre for Disease Prevention and Control, StockholmWHO Regional Office for Europe, CopenhagenSlide2

European Union and European Economic Area (EU/EEA)

1Slide3

HIV infections diagnosed, 2012

2

* Includes individuals (12%) originating from sub-Saharan African countries.

Characteristics of reported cases

 

EU/EEA

Number of HIV

diagnoses

29 381

Diagnoses

per

100 000 population5.8Percentage aged 15–24 years 10.6%Male-to-female ratio3.2Transmission mode (percentage)  Heterosexual33.8%*Men who have sex with men40.4%Injecting drug use6.1%Unknown18.7%

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide4

HIV infections diagnosed and reported, 2012

All cases, EU/EEA

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide5

HIV infections

diagnosed and reported, 2012Men who have sex with men, EU/EEA

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide6

HIV infections

diagnosed and reported, 2012

Injecting drug use, EU/EEASource: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide7

6

HIV

diagnoses in persons originating from countries with a generalised epidemic among all the heterosexually acquired infections, 2012 (n=9 944)Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide8

HIV

diagnoses in MSM among all reported HIV cases, by country, EU/EEA, 2012 (n=29 381)

7Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide9

Male-to-female

ratio of HIV infections, by country, EU/EEA, 2012 (n=29 327)

8Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide10

Percentage

of cases presenting with CD4

cell count <350/mm3 and <200/mm3, by mode of transmission, EU/EEA, 2012 (n=16 150)9

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide11

Rate

of reported HIV diagnoses, by year of diagnosis, in the

EU/EEA, 1984–201210Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide12

HIV infections reported, 2006-2012

Transmission mode and origin, adjusted for reporting delay

11Predominant transmission mode: men who have sex with men

Data were not included or not available from Estonia, Poland, Spain, Italy.

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide13

12

Conclusions (1)

HIV infection is of major public health importance in Europe, with evidence of continuing transmission in specific populations with no clear signs of overall decrease.Half of the HIV infections were diagnosed as late presenters with CD4 cell counts less than 350/mm3 blood.Heterogeneity exists in HIV epidemics in the EU/EEA:

Men who have sex with men accounted for majority of cases;One third of heterosexual cases have direct links to sub-Saharan Africa (areas with a generalised epidemic);

Despite low levels of HIV reported in IDU, increases continue in Greece and Romania.

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide14

Conclusions (2)

Interventions should be based on evidence and tailored to the local epidemiological situation and vulnerable populations such as MSM, IDU and migrant populations.

Wider access and uptake of HIV counselling and testing is needed to ensure earlier diagnosis and access to treatment – both to improve the longer term treatment outcomes for the individuals but also to prevent or reduce further transmission in the community.13

Source: ECDC/WHO. HIV/AIDS Surveillance in Europe, 2012Slide15

14

Report is available from:

www.ecdc.europa.eu